The Current Approach to Male Patients with Lower Urinary Tract Symptoms

ŞAHİN, Bahadır; ÇAM, Haydar Kamil

The Current Approach to Male Patients with Lower Urinary Tract Symptoms

Bahadır Şahin, (Marmara Üniversitesi, Pendik Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, İstanbul, Türkiye)

Haydar Kamil Çam (Marmara Üniversitesi Tıp Fakültesi, Üroloji Anabilim Dalı, İstanbul, Türkiye)

Journal of Urological Surgery

0 0

Yıl: 2021 Cilt: 8 Sayı: 2 Sayfa Aralığı: 130 - 134 Metin Dili: İngilizce İndeks Tarihi: 21-10-2021

The Current Approach to Male Patients with Lower Urinary Tract Symptoms

Öz:

Objective: The goal of this study was to investigate the current daily approach of urologists for the initial evaluation of men with lower urinarytract symptoms (LUTS) in accordance with the European Association of Urology (EAU) guidelines.Materials and Methods: An online survey was used to identify the daily practices of urologists for men over the age of 45 with LUTS. Based onthe EAU guidelines, an 11-item questionnaire was created. A link to the SurveyMonkey questionnaire was sent to members of a national urologyassociation along with an e-mail message. Moreover, the data were analysed after collecting all of the responses.Results: Out of 1.182 urologists who received an invitation message, 166 (14.04%) responded and completed the questionnaire. The mean age of theurologists who responded was 42.24+10.11. More than half of the participants (56.6%) work at centres that have a urology residency programme.Furthermore, the most commonly performed laboratory test in men with LUTS was urinalysis. Approximately 90% of urologists performed urinalysis.In addition, 84% of participants routinely measured prostate-specific antigen in every man between the ages of 45 and 75. In all men withLUTS, approximately half of the urologists routinely used renal function tests, urinary ultrasonography, post-void residual urine measurement,uroflowmetry, and symptom score assessment. For men with nocturia and/or storage phase symptoms, the majority of participants (69.9%) useda bladder diary. Moreover, urologists who worked at university hospitals were found to use bladder diaries significantly more frequently in theirclinical practice (p=0.037).Conclusion: We discovered that there was no clinical approach standard among urologists for men with LUTS

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Kupelian V, Wei JT, O’Leary MP, Kusek JW, Litman HJ, Link CL, McKinlay JB; BACH Survery Investigators. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med 2006;166:2381-2387.
2. Martin SA, Haren MT, Marshall VR, Lange K, Wittert GA; Members of the Florey Adelaide Male Ageing Study. Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World J Urol 2011;29:179-184.
3. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A; Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-178.
4. Taub DA, Wei JT. The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States. Curr Urol Rep 2006;7:272-281.
5. Gravas S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, Rieken M, Speakman MJ, Tikkinen KAO. EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO) 2020. European Association of Urology Guidelines. 2020 Edition., Vol presented at the EAU Annual Congress Amsterdam 2020. Arnhem, The Netherlands, European Association of Urology Guidelines Office, 2020.
6. Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 2015;22:1-6.
7. Loeb S. Guideline of guidelines: prostate cancer screening. BJU Int 2014;114:323-325.
8. Fowler FJ Jr, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, Barry MJ. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med 1998;104:526-532.
9. Ito K. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives. Int J Urol 2009;16:458- 464.
10. Novara G, Galfano A, Gardi M, Ficarra V, Boccon-Gibod L, Artibani W. Critical review of guidelines for BPH diagnosis and treatment strategy. European Urology Supplements 2006;5:418-429.
11. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE Jr, Gonzalez CM, Kaplan SA, Penson DF, Ulchaker JC, Wei JT. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011;185:1793-1803.
12. Bosch J, Abrams P, Cotterill N. Etiology, patient assessment and predicting outcome from therapy. Male lower urinary tract symptoms Montreal, Canada: International Consultation on Urological Diseases Male LUTS Guideline 2013:37-133.
13. Oelke M, Höfner K, Jonas U, de la Rosette JJ, Ubbink DT, Wijkstra H. Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur Urol 2007;52:827-834.
14. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM Jr, Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA; Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349:2387-2398.
15. Roehrborn CG. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study. BJU Int 2006;97:734-741.
16. Oelke M, Kirschner-Hermanns R, Thiruchelvam N, Heesakkers J. Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS 2011. Neurourol Urodyn 2012;31:322-326.
17. Idzenga T, Pel JJ, van Mastrigt R. Accuracy of maximum flow rate for diagnosing bladder outlet obstruction can be estimated from the ICS nomogram. Neurourol Urodyn 2008;27:97-98.
18. Cornu JN, Abrams P, Chapple CR, Dmochowski RR, Lemack GE, Michel MC, Tubaro A, Madersbacher S. A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis. Eur Urol 2012;62:877-890.
19. Weiss JP, Bosch JL, Drake M, Dmochowski RR, Hashim H, Hijaz A, Johnson TM, Juul KV, Nørgaard JP, Norton P, Robinson D, Tikkinen KA, Van Kerrebroeck PE, Wein AJ. Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011. Neurourol Urodyn 2012;31:330-339.

APA	ŞAHİN B, ÇAM H (2021). The Current Approach to Male Patients with Lower Urinary Tract Symptoms. , 130 - 134.
Chicago	ŞAHİN Bahadır,ÇAM Haydar Kamil The Current Approach to Male Patients with Lower Urinary Tract Symptoms. (2021): 130 - 134.
MLA	ŞAHİN Bahadır,ÇAM Haydar Kamil The Current Approach to Male Patients with Lower Urinary Tract Symptoms. , 2021, ss.130 - 134.
AMA	ŞAHİN B,ÇAM H The Current Approach to Male Patients with Lower Urinary Tract Symptoms. . 2021; 130 - 134.
Vancouver	ŞAHİN B,ÇAM H The Current Approach to Male Patients with Lower Urinary Tract Symptoms. . 2021; 130 - 134.
IEEE	ŞAHİN B,ÇAM H "The Current Approach to Male Patients with Lower Urinary Tract Symptoms." , ss.130 - 134, 2021.
ISNAD	ŞAHİN, Bahadır - ÇAM, Haydar Kamil. "The Current Approach to Male Patients with Lower Urinary Tract Symptoms". (2021), 130-134.

APA	ŞAHİN B, ÇAM H (2021). The Current Approach to Male Patients with Lower Urinary Tract Symptoms. Journal of Urological Surgery, 8(2), 130 - 134.
Chicago	ŞAHİN Bahadır,ÇAM Haydar Kamil The Current Approach to Male Patients with Lower Urinary Tract Symptoms. Journal of Urological Surgery 8, no.2 (2021): 130 - 134.
MLA	ŞAHİN Bahadır,ÇAM Haydar Kamil The Current Approach to Male Patients with Lower Urinary Tract Symptoms. Journal of Urological Surgery, vol.8, no.2, 2021, ss.130 - 134.
AMA	ŞAHİN B,ÇAM H The Current Approach to Male Patients with Lower Urinary Tract Symptoms. Journal of Urological Surgery. 2021; 8(2): 130 - 134.
Vancouver	ŞAHİN B,ÇAM H The Current Approach to Male Patients with Lower Urinary Tract Symptoms. Journal of Urological Surgery. 2021; 8(2): 130 - 134.
IEEE	ŞAHİN B,ÇAM H "The Current Approach to Male Patients with Lower Urinary Tract Symptoms." Journal of Urological Surgery, 8, ss.130 - 134, 2021.
ISNAD	ŞAHİN, Bahadır - ÇAM, Haydar Kamil. "The Current Approach to Male Patients with Lower Urinary Tract Symptoms". Journal of Urological Surgery 8/2 (2021), 130-134.